A PHASE-II TRIAL OF DIAZIQUONE (AZQ) IN MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
SLAYTON, RE
BLESSING, JA
CLARKEPEARSON, D
机构：
[1] RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60612
[2] ROSWELL PK CANC INST,GYNECOL ONCOL GRP,BUFFALO,NY
[3] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,DURHAM,NC 27710
来源：
INVESTIGATIONAL NEW DRUGS | 1991年 / 9卷 / 01期
关键词：
DIAZIQUONE; MIXED MESODERMAL SARCOMA; UTERUS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AZQ was given intravenously to 23 patients with mixed mesodermal sarcoma of the uterus refractory to conventional treatment at a dose of 22.5-30 mg/m2 q three weeks. There was one partial response lasting seven weeks and one drug-related death. Based upon the activity observed in this trial, there does not appear to be a significant role for AZQ as a salvage agent for mixed mesodermal sarcomas of the uterus at the dose and schedule tested.
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [31] Phase II trial of etoposide in leiomyosarcoma of the uterus: A gynecologic oncology group study
    Thigpen, T
    Blessing, JA
    Yordan, E
    Valea, F
    Vaccarello, L
    GYNECOLOGIC ONCOLOGY, 1996, 63 (01) : 120 - 122
  • [32] PHASE-II TRIAL OF PIPERAZINEDIONE (NSC 135758) IN THE TREATMENT OF ADVANCED OR RECURRENT CARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    ARSENEAU, JC
    HOMESLEY, HD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 261 - 263
  • [33] PHASE-II CLINICAL-STUDY OF TAMOXIFEN IN ADVANCED ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAVIK, M
    PETTY, WM
    BLESSING, JA
    CREASMAN, WT
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1984, 68 (05): : 809 - 811
  • [34] PHASE-II STUDY OF VINBLASTINE IN PREVIOUSLY TREATED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    BARNES, W
    BALL, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 470 - 471
  • [35] PHASE-II STUDY OF MAYTANSINE IN THE TREATMENT OF ADVANCED OR RECURRENT ADENOCARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    EHRLICH, CE
    CREASMAN, WT
    CURRY, S
    BLESSING, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (03): : 273 - 275
  • [36] PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    SUTTON, GP
    HOMESLEY, HD
    PARK, R
    CANCER TREATMENT REPORTS, 1986, 70 (02): : 309 - 310
  • [37] PHASE-II TRIAL OF MITOGUAZONE IN CHILDREN WITH LEUKEMIA AND LYMPHOMA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    KINNEY, TR
    KRISCHER, JP
    STARLING, KA
    ALVARADO, C
    KAMEN, B
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1041 - 1042
  • [38] PHASE-II TRIAL OF MITOXANTRONE IN MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    ALBERTS, DS
    BALCERZAK, SP
    BONNET, JD
    STEPHENS, RL
    CANCER TREATMENT REPORTS, 1985, 69 (11): : 1321 - 1323
  • [39] PHASE-II TRIAL OF BISANTRENE IN HEPATOCELLULAR-CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BROWN, TD
    FLEMING, TR
    SHILDT, RA
    COWAN, JD
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1101 - 1102
  • [40] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH ADVANCED SARCOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COWAN, JD
    GEHAN, E
    RIVKIN, SE
    JONES, SE
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 685 - 686
12345